EXEL
Exelixis Inc.Stock · Health CareNasdaq Composite 0.03% · Russell 1000 0.02% · Russell 3000 0.02% · US Stock Market 0.02%$58.33-0.27%
as of market close, Sep 18, 2026
☾ AH — —
EXEL financial statements
The full income statement, balance sheet, and cash-flow statement for Exelixis Inc. (EXEL), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 285.3M2024-09 285.6M2025-01 279.9M2025-04 272.7M2025-07 269.2M2025-10 268.1M2026-01 259.7M2026-04 251.4M2026-07 247.8M-13.1% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofJan 2 ’26 | as ofJan 3 ’25 | as ofDec 29 ’23 | as ofDec 30 ’22 | as ofDec 31 ’21 | |
| Revenue | 2.32B+7.0% | 2.17B+18.5% | 1.83B+13.6% | 1.61B+12.3% | 1.43B+45.3% | |
| Cost of revenue | 83.7M+9.8% | 76.2M+5.1% | 72.5M+25.3% | 57.9M+9.5% | 52.9M+45.8% | |
| Research & development | 825M-9.4% | 910M-12.8% | 1.04B+17.1% | 892M+28.6% | 694M+26.6% | |
| Selling, general & administrative | 519M+5.4% | 492M-9.3% | 543M+18.0% | 460M+14.5% | 402M+36.9% | |
| Restructuring | 20.5M-39.1% | 33.7M | 0.00 | 0.00 | — | |
| Operating income | 872M+44.3% | 605M+253.8% | 171M-15.2% | 201M-29.7% | 287M+160.5% | |
| Other non-operating income | -198K-48.9% | -133K-243.0% | 93.0K+147.2% | -197K-7.1% | -184K-120.2% | |
| Income tax | 159M-1.1% | 160M+222.3% | 49.8M-4.4% | 52.1M-17.5% | 63.1M+231.1% | |
| Net income | 783M+50.1% | 521M+150.9% | 208M+14.0% | 182M-21.1% | 231M+106.7% | |
| $2.78+58.0% | $1.76+170.8% | $0.65+16.1% | $0.56-22.2% | $0.72+105.7% | ||
| EPS (basic) | $2.88+60.0% | $1.80+176.9% | $0.65+14.0% | $0.57-21.9% | $0.73+102.8% | |
| Weighted-avg shares (basic) | 272M-6.4% | 290M-8.8% | 318M-1.0% | 322M+2.1% | 315M+2.1% | |
| Weighted-avg shares (diluted) | 282M-4.8% | 296M-7.9% | 321M-1.0% | 325M+0.7% | 322M+1.4% | |
| Balance Sheet | as ofJan 2 ’26 | as ofJan 3 ’25 | as ofDec 29 ’23 | as ofDec 30 ’22 | as ofDec 31 ’21 | |
| 1.44B-1.7% | 1.47B+11.4% | 1.32B-18.6% | 1.62B-11.8% | 1.83B+26.9% | ||
| Cash & equivalents | 482M+122.0% | 217M-17.3% | 263M-47.5% | 501M-22.6% | 647M+102.7% | |
| Short-term investments | 577M-35.5% | 894M+22.1% | 732M-9.3% | 807M-1.5% | 820M-7.6% | |
| Accounts receivable | 287M+8.1% | 265M+11.8% | 237M+10.5% | 215M-24.0% | 283M+75.7% | |
| Inventory | 21.7M-3.1% | 22.4M+29.2% | 17.3M-48.0% | 33.3M+21.1% | 27.5M+31.1% | |
| Prepaid expenses | 75.6M+10.4% | 68.5M+0.8% | 67.9M+9.2% | 62.2M+8.1% | 57.5M+0.9% | |
| 2.84B-3.5% | 2.95B+0.2% | 2.94B-4.2% | 3.07B+17.4% | 2.62B+22.4% | ||
| Property, plant & equipment | 99.0M-17.1% | 119M-7.3% | 129M+16.4% | 111M+6.3% | 104M+54.4% | |
| Operating lease right-of-use | 159M-7.8% | 173M-26.0% | 233M-0.7% | 235M+420.4% | 45.1M+4.9% | |
| Goodwill | 63.7M+0.0% | 63.7M+0.0% | 63.7M+0.0% | 63.7M+0.0% | 63.7M+0.0% | |
| Long-term investments | 604M-5.3% | 637M-12.5% | 729M-3.7% | 757M+103.9% | 371M+12.2% | |
| Deferred tax assets | 293M-30.3% | 420M+16.3% | 361M+56.3% | 231M+107.0% | 112M-28.7% | |
| Other non-current assets | — | — | — | — | 131M+78.5% | |
| 406M+0.5% | 404M+2.4% | 394M+21.6% | 324M-3.9% | 338M+65.0% | ||
| Accounts payable | 29.6M-22.4% | 38.2M+13.1% | 33.8M+3.4% | 32.7M+34.7% | 24.3M+2.6% | |
| Deferred revenue | 1.11M-59.3% | 2.74M-49.3% | 5.41M-27.8% | 7.49M-4.2% | 7.81M+336.5% | |
| Current lease liability | 27.9M+11.5% | 25.0M-2.7% | 25.7M+45.6% | 17.7M+243.8% | 5.14M+69.8% | |
| Other current liabilities | 125M+32.0% | 95.0M-12.4% | 108M+37.4% | 78.9M+47.9% | 53.4M+20.1% | |
| 683M-2.9% | 703M+3.7% | 678M+16.4% | 583M+43.7% | 406M+57.1% | ||
| Deferred revenue (non-current) | 6.11M+80.2% | 3.39M-38.6% | 5.52M-16.1% | 6.58M-24.7% | 8.74M+132.7% | |
| Non-current lease liability | 173M-9.3% | 191M+0.5% | 190M-0.1% | 190M+270.9% | 51.3M+4.5% | |
| Operating lease liability (total) | 201M-6.9% | 216M+0.1% | 216M+3.8% | 208M+268.4% | 56.4M+8.2% | |
| Other non-current liabilities | 104M-4.1% | 109M+15.6% | 94.2M+37.5% | 68.5M+754.2% | 8.02M+1012.8% | |
| 2.16B-3.7% | 2.24B-0.9% | 2.26B-9.0% | 2.49B+12.6% | 2.21B+17.6% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 262K-7.1% | 282K-6.9% | 303K-6.5% | 324K+1.6% | 319K+2.2% | |
| Additional paid-in capital | 2.23B-4.7% | 2.34B-4.0% | 2.44B-3.8% | 2.54B+4.5% | 2.43B+4.6% | |
| Retained earnings | -76.8M+22.1% | -98.6M+43.1% | -173M-406.5% | -34.2M+84.2% | -217M+51.6% | |
| Accumulated other comprehensive income | 3.48M+358.1% | -1.35M+64.1% | -3.75M+74.2% | -14.5M-1815.7% | -758K-116.9% | |
| Total liabilities & equity | 2.84B-3.5% | 2.95B+0.2% | 2.94B-4.2% | 3.07B+17.4% | 2.62B+22.4% | |
| Common shares issued | 262M-6.8% | 282M-7.0% | 303M-6.5% | 324M+1.6% | 319M+2.3% | |
| Common shares outstanding | 262M-6.8% | 282M-7.0% | 303M-6.5% | 324M+1.6% | 319M+2.3% | |
| Shares outstanding (cover) | 260M-7.2% | 280M-7.7% | 303M-6.4% | 324M+1.5% | 319M+2.4% | |
| Cash Flow | as ofJan 2 ’26 | as ofJan 3 ’25 | as ofDec 29 ’23 | as ofDec 30 ’22 | as ofDec 31 ’21 | |
| 884M+26.3% | 700M+110.0% | 333M-8.1% | 363M-9.5% | 401M+91.8% | ||
| Depreciation & amortization | 29.1M+0.9% | 28.8M+12.0% | 25.7M+23.2% | 20.9M+53.2% | 13.6M+49.1% | |
| Share-based compensation | 113M+20.4% | 93.8M-11.8% | 106M-1.1% | 108M-10.2% | 120M+14.0% | |
| Deferred income taxes | 126M+312.3% | -59.5M+55.4% | -133M-120.7% | -60.4M-229.7% | 46.5M+204.8% | |
| Change in receivables | 21.4M-23.4% | 27.9M+23.5% | 22.6M+133.8% | -66.8M-154.6% | 122M+188.0% | |
| Change in inventory | -12.2M-124.2% | -5.45M-142.0% | 13.0M+11.1% | 11.7M-11.6% | 13.2M-39.7% | |
| Change in payables | -50.2M-129.2% | -21.9M-143.7% | 50.1M+114.5% | 23.4M-57.6% | 55.1M+9.1% | |
| 350M+400.1% | -117M-333.3% | -27.0M+94.9% | -524M-1122.9% | -42.9M+67.3% | ||
| Capital expenditure | 8.43M-70.4% | 28.4M-29.7% | 40.5M+46.1% | 27.7M-48.9% | 54.2M+78.7% | |
| Free cash flow | 876M+30.4% | 672M+129.3% | 293M-12.6% | 335M-3.4% | 347M+94.0% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchases of investments | — | — | 902M-37.8% | 1.45B+6.9% | 1.36B+26.8% | |
| Sales/maturities of investments | — | — | 1.04B-2.5% | 1.06B-22.8% | 1.38B+42.2% | |
| -970M-54.2% | -629M-15.2% | -546M-93282.9% | 586K+104.0% | -14.8M+41.1% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 948M+45.3% | 652M+18.5% | 550M | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | — | — | — | — | 0.00 | |
| Net change in cash | 265M+681.1% | -45.6M+81.0% | -240M-48.7% | -161M-147.0% | 343M+551.9% | |
| Income taxes paid | 155M-8.9% | 170M-8.2% | 186M+45.2% | 128M+886.7% | 13.0M+214.9% | |
| Valuation Ratios | as ofJan 2 ’26 | as ofJan 3 ’25 | as ofDec 29 ’23 | as ofDec 30 ’22 | as ofDec 31 ’21 | |
| Market cap | 11.3B+19.0% | 9.51B+30.7% | 7.27B+39.9% | 5.20B-11.0% | 5.84B-6.2% | |
| P/E | 14.5×-20.7% | 18.2×-47.9% | 35.0×+22.8% | 28.5×+12.8% | 25.3×-38.3% | |
| P/S | 4.9×+11.3% | 4.4×+10.3% | 4.0×+23.2% | 3.2×-20.7% | 4.1×-37.4% | |
| P/B | 5.2×+23.6% | 4.2×+31.9% | 3.2×+53.8% | 2.1×-20.9% | 2.6×-21.4% | |
| P/FCF | 12.9×-8.7% | 14.2×-43.0% | 24.8×+60.0% | 15.5×-7.9% | 16.8×-16.0% | |
| Earnings yield | 6.9%+26.1% | 5.5%+91.9% | 2.9%-18.5% | 3.5%-11.4% | 4.0%+61.9% | |
| FCF yield | 7.7%+9.6% | 7.1%+75.4% | 4.0%-37.5% | 6.4%+8.6% | 5.9%+19.1% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: EXEL’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all EXEL filings on SEC EDGAR → Not investment advice.